Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

INVO Fertility, Inc.(IVF US)

$1.91-0.2310.93%Ext:$1.85-0.062.99%(Market Closed · 23:59:27 UTC)
ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
IVF US​
Ask AI

INVO Fertility, Inc. — Company Profile

INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.

Sector
Industrials
Industry
Commercial Services & Supplies
Exchange
UQ
CEO
Steven Shum
Headquarters
Sarasota, FL, US
IPO Date
Nov 2, 2020
Employees
41
Website
www.invofertility.com

Key Metrics

Price
$0.85
Market Cap
$1.53M
Revenue (TTM)
$6.84M
Net Income (TTM)
$-23323054.00
EPS (TTM)
-214.64
P/E (TTM)
-0.07
P/B (TTM)
0.21
Dividend Yield
0.00%
ROE (TTM)
-322.85%
ROA (TTM)
-115.35%
Operating Margin
-85.36%
Beta
-1.78

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.

Website
www.invofertility.com
Location
Sarasota, FL, US
Phone978 878 9505
Employees41
CEOSteven Shum
Sector
Industrials
Industry
Commercial Services & Supplies
IPO DateNov 2, 2020

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

News

  • INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 202627 Oct
  • Head to Head Comparison: Agilon Health (NYSE:AGL) & INVO Fertility (NASDAQ:IVF)11 Oct
  • INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference25 Sep
  • Financial Analysis: INVO Fertility (NASDAQ:IVF) vs. P3 Health Partners (NASDAQ:PIIIW)2 Sep
  • INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference28 Aug
  • INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International20 Aug
  • INVO Fertility Stock Surges Following Q2 Earnings Beat17 Aug
  • INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability17 Aug

Key Stats

Trading

Px/Chg 1D$0.86 / -5.06%
Prev Close$0.98
% of 52Wk H1.17%
Avg Volume1.61M
Beta-1.78
Mkt Cap1.53M
FD Mkt Cap1.76M

Float

Shrs Out/Float1.79M / 1.78M
Short Float0.55%
Days to Cover1.00
Stock Repurchased$4.00M

Current Valuation

EV5.26M
EV/EBITDA-2.08
EV/Sales0.77
P/B0.21
P/S0.22
FCF Yield0.88%
ROE-322.85%
ROA-115.35%
Current Ratio0.27

Estimates

P/E-0.07
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMar '22Mar '23Mar '24Mar '25Oct '26
PRICE-BASED RATIOS
Price / Earnings-16.25-69.03-11.01-3.32-1.123.21
Price / Sales53.54110.42145.928.831.560.96
Price / Book Value-5.8062.84-122.7229.880.800.21
Price / Free Cash Flow3.35-70.84-18.13-5.13-3.23114.10
ENTERPRISE VALUE METRICS
Enterprise Value134.3455.8122.238.849.75.3
Enterprise Value / Sales56.38109.57148.5712.837.623.32
Enterprise Value / EBITDA-21.86-87.34-11.36-5.63-6.962.00
Enterprise Value / EBIT-21.09-84.65-11.28-5.47-6.172.11

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue13.2%4.20.83.06.56.8
Gross Income-10.9%4.0-0.01.12.92.5
EBITDA-9.5%-5.2-10.8-6.9-7.1-3.5
EBIT-6.1%-5.4-10.8-7.1-8.1-4.2
Net Income36.8%-6.7-10.9-8.0-9.1-23.3
EPS (Diluted)-50.5%-1,099.64-1,570.91-489.96-219.56-66.11
BALANCE SHEET
Cash & ST Inv-22.2%5.70.10.20.72.1
Total Assets17.9%10.53.718.546.420.2
Total Liabilities42.5%3.24.717.633.713.0
Total Shareholder Equity-29.7%7.3-1.00.912.77.2
CASH FLOW
Net Operating Cash Flow3.9%-6.0-6.6-4.8-3.0-7.0
Cap Ex-44.4%-0.5-0.0-0.4-0.2-0.0
Free Cash Flow2.1%-6.5-6.6-5.2-3.2-7.1

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)0.57
Basic Shares1.79
Market Cap1.0
Diluted Shares0.12
Fully Diluted Shares Outstanding0.12
Fully Diluted Market Cap0.1
+Consolidated Debt3.4
−In-the-Money Convertible Debt—
+Capital Leases1.4
+Operating Leases—
−Cash & Equivalents-2.1
−Short-term Investments-
+Total Preferred2.4
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value4.8

Segment data

Revenue

by Products and services

  • Clinic Revenue98%
  • Product2%

Related companies

Apple Inc.

AAPL US

Kla Corp

KLAC US

Medtronic Public Limited Company

MDT US

Stryker Corp

SYK US

3M Company

MMM US

Northrop Grumman Corp /DE/

NOC US

Coherent Corp.

COHR US

Boston Scientific Corp

BSX US

Lenovo Group Ltd

LNVGY US

Garmin Ltd

GRMN US

HOYA Corporation

HOCPY US

Becton Dickinson & Co

0R19 LN